MDM2 immunohistochemistry and MDM2 amplification can help confirm a diagnosis of DDLPS and distinguish DDLPS from other undifferentiated sarcomas in the relevant clinical context [47]. The gene discussed is MDM2; the disease is dedifferentiated liposarcoma.